Nomura/Instinet analyst Saion Mukherjee downgraded Gland Pharma Ltd (GLAND:IN) from Neutral to Reduce with a price target of INR1,819.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE